Published by Iain Gilbert on 30th October 2020
(Sharecast News) - Gene and cell therapy group Oxford Biomedica said on Friday that partner Axovant Gene Therapies had pushed out the start date for its trial into a Parkinson's disease treatment.
URL: http://www.digitallook.com/dl/news/story/31374227/...